Therapeutic Solutions International, Inc. (TSOI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Apr 25, 2025, 4:00 PM EDT
TSOI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 0.09 | 0.1 | 0.21 | 0.15 | 0.06 | 0.03 | Upgrade
|
| Revenue Growth (YoY) | 1.89% | -52.12% | 41.66% | 132.85% | 127.97% | 689.18% | Upgrade
|
| Cost of Revenue | 0.03 | 0.04 | 0.08 | 0.04 | 0.01 | 0 | Upgrade
|
| Gross Profit | 0.06 | 0.06 | 0.13 | 0.1 | 0.05 | 0.02 | Upgrade
|
| Selling, General & Admin | 3.41 | 1.49 | 1.95 | 1.61 | 1.34 | 0.68 | Upgrade
|
| Research & Development | 0.24 | 0.56 | 1.45 | 0.79 | 0.56 | 0.03 | Upgrade
|
| Operating Expenses | 3.65 | 2.05 | 3.41 | 2.41 | 1.9 | 1.07 | Upgrade
|
| Operating Income | -3.59 | -1.99 | -3.28 | -2.3 | -1.85 | -1.04 | Upgrade
|
| Interest Expense | -0.37 | -0.42 | -0.65 | -0.61 | -0.3 | -0.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.13 | 0.02 | 0.05 | -0.04 | -0.05 | -0.3 | Upgrade
|
| EBT Excluding Unusual Items | -3.83 | -2.39 | -3.88 | -2.96 | -2.2 | -1.7 | Upgrade
|
| Other Unusual Items | 0.08 | 0.17 | - | - | - | - | Upgrade
|
| Pretax Income | -3.74 | -2.22 | -3.88 | -2.96 | -2.2 | -1.7 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Earnings From Continuing Operations | -3.74 | -2.22 | -3.88 | -2.96 | -2.2 | -1.7 | Upgrade
|
| Net Income to Company | -3.74 | -2.22 | -3.88 | -2.96 | -2.2 | -1.7 | Upgrade
|
| Minority Interest in Earnings | 1.33 | 0.05 | 0.06 | - | - | - | Upgrade
|
| Net Income | -2.41 | -2.17 | -3.81 | -2.96 | -2.2 | -1.7 | Upgrade
|
| Net Income to Common | -2.41 | -2.17 | -3.81 | -2.96 | -2.2 | -1.7 | Upgrade
|
| Shares Outstanding (Basic) | 4,275 | 3,169 | 2,528 | 2,263 | 1,912 | 1,284 | Upgrade
|
| Shares Outstanding (Diluted) | 4,275 | 3,169 | 2,528 | 2,263 | 1,912 | 1,284 | Upgrade
|
| Shares Change (YoY) | 47.77% | 25.35% | 11.71% | 18.37% | 48.88% | 43.18% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -0.48 | -1.07 | -1.04 | -0.98 | -0.67 | -0.31 | Upgrade
|
| Gross Margin | 65.80% | 62.86% | 61.58% | 70.85% | 79.59% | 89.03% | Upgrade
|
| Operating Margin | -4211.92% | -2006.67% | -1586.03% | -1578.80% | -2950.78% | -3794.02% | Upgrade
|
| Profit Margin | -2824.94% | -2191.86% | -1844.58% | -2029.00% | -3509.68% | -6173.20% | Upgrade
|
| Free Cash Flow Margin | -567.41% | -1082.34% | -501.98% | -671.08% | -1066.55% | -1130.08% | Upgrade
|
| EBITDA | -3.28 | -1.67 | -3.03 | -2.29 | -1.84 | -1.04 | Upgrade
|
| D&A For EBITDA | 0.31 | 0.31 | 0.24 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EBIT | -3.59 | -1.99 | -3.28 | -2.3 | -1.85 | -1.04 | Upgrade
|
| Advertising Expenses | - | 0 | 0 | - | - | - | Upgrade
|
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.